Lymphocytic Leukemia, Acute Clinical Trials

A listing of Lymphocytic Leukemia, Acute medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials
Online Trials

Male only (1)
Female only (2)
Any (473)
N/A (1)

Phase 1 (111)
Phase 2 (91)
Phase 3 (25)
Phase 4 (10)
Phase 1/2 (70)
Phase 2/3 (9)
Unknown (161)

Interventional (389)
Observational (83)

M.D. Anderson Cancer Center (18)
National Cancer Institute (NCI) (12)
St. Jude Children's Research Hospital (12)
City of Hope Medical Center (11)
The First Affiliated Hospital of Soochow University (8)
Children's Oncology Group (7)
Assistance Publique - Hôpitaux de Paris (6)
Beijing Boren Hospital (6)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology (6)
Fred Hutchinson Cancer Center (6)
Hebei Senlang Biotechnology Inc., Ltd. (6)
Masonic Cancer Center, University of Minnesota (6)
PETHEMA Foundation (6)
Rigshospitalet, Denmark (6)
Sanofi (6)
Zhejiang University (6)
Amgen (5)
Fred Hutchinson Cancer Research Center (5)
Memorial Sloan Kettering Cancer Center (5)
University of Pennsylvania (5)
Dana-Farber Cancer Institute (4)
Gruppo Italiano Malattie EMatologiche dell'Adulto (4)
He Huang (4)
Hospital General de Mexico (4)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (4)
Shenzhen Geno-Immune Medical Institute (4)
Aarhus University Hospital (3)
Baylor College of Medicine (3)
Center for International Blood and Marrow Transplant Research (3)
Chinese PLA General Hospital (3)
Duke University (3)
Goethe University (3)
Institute of Hematology and Blood Transfusion, Czech Republic (3)
Orca Biosystems, Inc. (3)
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd (3)
Sun Yat-sen University (3)
University of Birmingham (3)
University of Chicago (3)
University of Michigan Rogel Cancer Center (3)
University of Nebraska (3)
Washington University School of Medicine (3)
Wuhan Union Hospital, China (3)
iCell Gene Therapeutics (3)
Celgene (2)
Children's Cancer Group, China (2)
Chongqing Precision Biotech Co., Ltd (2)
Crystal Mackall, MD (2)
Emory University (2)
First Affiliated Hospital Xi'an Jiaotong University (2)
H. Lee Moffitt Cancer Center and Research Institute (2)
Institut de Recherches Internationales Servier (2)
Juventas Cell Therapy Ltd. (2)
Kai Lin Xu; Jun Nian Zheng (2)
Mats Heyman (2)
Medical College of Wisconsin (2)
National University Hospital, Singapore (2)
Newave Pharmaceutical Inc (2)
Novartis Pharmaceuticals (2)
Ohio State University Comprehensive Cancer Center (2)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. (2)
Roswell Park Cancer Institute (2)
Seoul National University Hospital (2)
Shenzhen BinDeBio Ltd. (2)
St. Anna Kinderkrebsforschung (2)
St. Petersburg State Pavlov Medical University (2)
Stanford University (2)
Syndax Pharmaceuticals (2)
Takeda (2)
The Hospital for Sick Children (2)
Therapeutic Advances in Childhood Leukemia Consortium (2)
UNC Lineberger Comprehensive Cancer Center (2)
University of Alberta (2)
University of British Columbia (2)
University of Colorado, Denver (2)
University of Pittsburgh (2)
University of Virginia (2)
Wake Forest University Health Sciences (2)
Yan'an Affiliated Hospital of Kunming Medical University (2)
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China (1)
AO GENERIUM (1)
AVM Biotechnology LLC (1)
AbbVie (1)
Acacia Pharma Ltd (1)
Adaptive Biotechnologies (1)
Afyonkarahisar Health Sciences University (1)
Ain Shams University (1)
Alliance for Clinical Trials in Oncology (1)
Ann & Robert H Lurie Children's Hospital of Chicago (1)
Aristotle University Of Thessaloniki (1)
Ascentage Pharma Group Inc. (1)
Assiut University (1)
Autolus Limited (1)
AvenCell Europe GmbH (1)
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna (1)
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1)
Bambino Gesù Hospital and Research Institute (1)
Bandim Health Project (1)
Baptist Health South Florida (1)
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology (1)
Benjamin Tomlinson (1)

No (446)
Yes (31)

Updated trials (126)

No (477)

I am/have/had

I am/have/hadlymphoid leukemia

I am/have/hadgraft versus host disease

I am/have/hadcell transplantation

I am/have/hadmyeloid leukemia

I am/have/hadremission

I am/have/hadcancer

I am/have/hadlymphoma

I am/have/hadlymphoblastic lymphoma

I am/have/hadacute leukemia

I am/have/hadchronic myeloid leukemia

I am/have/hadhematologic malignancy

I am/have/hadhodgkin's disease

I am/have/hadmyeloproliferative syndromes

I am/have/hadb-cell acute lymphoblastic leukemia

I am/have/hadtotal body irradiation

I am/have/hadminimal residual disease

I am/have/hadtyrosine

I am/have/hadresidual tumor

I am/have/hadphiladelphia chromosome

I am/have/hadtransplant conditioning

added new label for I am/have/had

I am looking for

I am looking forasparaginase

I am looking forcyclophosphamide

I am looking formethotrexate

I am looking forpegaspargase

I am looking forcytarabine

I am looking forvincristine

I am looking formercaptopurine

I am looking forfludarabine

I am looking fortyrosine

I am looking fordaunorubicin

I am looking foretoposide

I am looking forclofarabine

I am looking forblinatumomab

I am looking fordexamethasone

I am looking forhydroxyurea

I am looking fordasatinib

I am looking forponatinib

I am looking forthiotepa

I am looking forinotuzumab

I am looking forimatinib

added new label for I am looking for

Advanced Filters

Found 477 clinical trials

Featured trial

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For pediatric ages
For all genders
Recruiting

AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)

112 views
08 Nov, 2020
1 location

Featured trial

For pediatric ages
For all genders
Recruiting

AALL0434: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

171 views
08 Nov, 2020
1 location

Featured trial

For pediatric ages
For all genders
Recruiting

AALL08B1: Risk-Based Classification System of Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

112 views
08 Nov, 2020
1 location

Featured trial

Phase 3
For pediatric ages
For all genders
Recruiting

AALL1131, A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789) in the Very High Risk Stratum.

216 views
08 Nov, 2020
1 location

Featured trial

Phase 3
For pediatric ages
Recruiting

AALL0631: A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND #76431; NSC# 617807)

AALL0631: A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701

365 views
08 Nov, 2020
1 location

Multi-country trial
Phase 1
Recruiting in 10s
Interventional Study
For all genders
Recruiting

A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients

The study aims to evaluate the safety and tolerability of subcutaneous (SC) blinatumomab for treatment of Acute Lymphoblastic Leukemia (ALL) and to determine the maximum tolerated dose (MTD

0 views
01 May, 2022
19 locations

Phase 1
For adults
Recruiting in 10s
Interventional Study
For all genders
Recruiting

CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia

This is a single arm, open-label, single-center, phase I/II study to determine the safety and efficacy of CD19 CAR-T( ssCART-19) combined with feeding T cells (FTCs) as consolidation therapy in patients diagnosed with de novo Philadelphia chromosome positive CD19+ B-ALL. The study will contain the following sequential phases: screening, lymphocyte …

0 views
24 May, 2022
1 location

Phase 2
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
For all genders
Hematology
Recruiting

Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia

Assessment of of the biological effects of curcumin on microbiota in children with acute lymphoblastic leukemia

0 views
24 Sep, 2021

Recruiting in 100s
Interventional Study
For all genders
Recruiting

Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years

This study proposes to provide adequate treatment and is based on current scientific evidence for elderly patients with ALL Bcr / Abl positive. To determine whether low-dose chemotherapy associated with imatinib or dasatinib has acceptable tolerability in elderly patients. To determine whether this association can increase the rate and quality …

1 views
22 Mar, 2022
1 location

Phase 4
Recruiting in 10s
Interventional Study
For all genders
Recruiting

Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE

20-25% of patients over 15 years with acute lymphoblastic leukemia (ALL) have the Philadelphia chromosome or BCR-ABL rearrangement. Traditionally, intensive chemotherapy followed by

103 views
26 Mar, 2022
73 locations